Physician profile
Don Morring
NPI 1437479797
$3,581.68
in general payments reported to CMS, 2019-2025
11 companies · $2,667 in 2025
The $2,667 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $14.44 · 2021: $73.19 · 2022: $246 · 2024: $98.10 · 2025: $2,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $264.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,559.47 | 2022-2025 | |
| Davol INC. | $589.07 | 2019-2022 | |
| Boston Scientific Corporation | $134.60 | 2024-2025 | Spyglass Discover |
| Abbvie INC. | $83.07 | 2021-2025 | |
| Medtronic, INC. | $56.10 | 2021-2025 | Transorb |
| Biotissue Holdings INC. | $41.24 | 2024 | |
| Innocoll Pharmaceuticals Limited | $35.70 | 2022 | |
| Solventum Corporation | $26.15 | 2025 | Prevena, V.A.C. Veraflo, Abthera Advance |
| Antares Pharma, INC. | $24.33 | 2024 | Xyosted |
| Tela Bio, INC. | $17.51 | 2021 | |
| Integra Lifesciences Corporation | $14.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Morring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.